Literature DB >> 21211195

The value of chest CT scan and tumor markers detection in sputum for early diagnosis of peripheral lung cancer.

Xu Wang1, Aihong Cao, Mengqing Peng, Chunfeng Hu, Delin Liu, Tao Gu, Hui Liu.   

Abstract

BACKGROUND: To investigate the diagnostic value of chest CT scan combined with telomerase activity and p16 gene methylation from exfoliated cells of sputum in 55 cases of solitary pulmonary nodules (SPN; ≤30 mm)suspected early peripheral lung cancer.
METHODS: The sputum specimens from 34 cases of cancer nodules and 21 cases of benign lesion were detected for telomerase activity by TRAP-PCR-ELISA and p16 gene methylation by PCR-based methylation analysis.
RESULTS: The qualitative diagnostic accuracy of CT scan was 61.8%(34/55) for SPN provided by pathology. Cytology analysis of sputum was positive in 13 cases (38.2%). Telomerase activity was positive in 29 cases: sensitivity was 79.4%, specificity was 90.5%, accuracy was 83.6%; p16 gene methylation was found in 11 cases: sensitivity was 32.4%, specificity was 100.0%, and accuracy was 58.2%. The sensitivity was increased to 86.1% by combination of telomerase activity and p16 gene methylation. Compared with nodules without malignant CT signs, expression of telomerase activity and p16 methylation of SPN with malignant CT signs (lobulation or spiculate protuberance or spicule sign) had a significant difference (P < 0.01).
CONCLUSIONS: The results suggest that chest CT scan combined with telomerase activity and p16 gene methylation detection in sputum for patients with peripheral lung cancer may enhance the diagnostic value of radiology and conventional cytology.

Entities:  

Year:  2004        PMID: 21211195     DOI: 10.3779/j.issn.1009-3419.2004.01.15

Source DB:  PubMed          Journal:  Zhongguo Fei Ai Za Zhi        ISSN: 1009-3419


  7 in total

Review 1.  The Indirect Efficacy Comparison of DNA Methylation in Sputum for Early Screening and Auxiliary Detection of Lung Cancer: A Meta-Analysis.

Authors:  Di Liu; Hongli Peng; Qi Sun; Zhongyao Zhao; Xinwei Yu; Siqi Ge; Hao Wang; Honghong Fang; Qing Gao; Jiaonan Liu; Lijuan Wu; Manshu Song; Youxin Wang
Journal:  Int J Environ Res Public Health       Date:  2017-06-23       Impact factor: 3.390

2.  Relationship between computed tomography morphology and prognosis of patients with stage I non-small cell lung cancer.

Authors:  Jun Ma; Yun-Long Yang; Ye Wang; Xue-Wei Zhang; Xue-Song Gu; Zhen-Chang Wang
Journal:  Onco Targets Ther       Date:  2017-04-21       Impact factor: 4.147

3.  An epigenetic classifier for early stage lung cancer.

Authors:  Yun Su; Hong Bin Fang; Feng Jiang
Journal:  Clin Epigenetics       Date:  2018-05-22       Impact factor: 6.551

4.  P16INK4a gene promoter methylation as a biomarker for the diagnosis of non-small cell lung cancer: An updated meta-analysis.

Authors:  Lei Tuo; Sha Sha; Zhang Huayu; Ke Du
Journal:  Thorac Cancer       Date:  2018-06-21       Impact factor: 3.500

5.  High-Throughput Detection of Multiple miRNAs and Methylated DNA by Droplet Digital PCR.

Authors:  Ning Li; Pushpa Dhilipkannah; Feng Jiang
Journal:  J Pers Med       Date:  2021-04-29

6.  Comparison of the accuracy of 99mTc-3P4-RGD2 SPECT and CT in diagnosing solitary pulmonary nodules.

Authors:  Haishan Zhang; Shi Gao; Bin Chen; Guanghui Cheng
Journal:  Oncol Lett       Date:  2016-08-17       Impact factor: 2.967

Review 7.  Non-blood circulating tumor DNA detection in cancer.

Authors:  Muyun Peng; Chen Chen; Alicia Hulbert; Malcolm V Brock; Fenglei Yu
Journal:  Oncotarget       Date:  2017-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.